Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
50
GHRS Quote, Financials, Valuation and Earnings
Last price:
$15.32
Seasonality move
:
-3.21%
Day range:
$14.30 - $15.50
52-week range:
$6.72 - $20.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.27x
Volume:
221.4K
Avg. volume:
358.7K
1-year change:
91.88%
Market cap:
$952.2M
Revenue:
--
EPS (TTM):
-$0.73
Analysts' Opinion
-
Consensus RatingGH Research Plc has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $30.38, GH Research Plc has an estimated upside of 97.88% from its current price of $15.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $19.00 representing 100% downside risk from its current price of $15.35.
Fair Value
-
According to the consensus of 5 analysts, GH Research Plc has 97.88% upside to fair value with a price target of $30.38 per share.
GHRS vs. S&P 500
-
Over the past 5 trading days, GH Research Plc has overperformed the S&P 500 by 3.95% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
GH Research Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
GH Research Plc has grown year-over-year revenues for 0 quarters straight. In the most recent quarter GH Research Plc reported revenues of --.
Earnings Growth
-
GH Research Plc has grown year-over-year earnings for 2 quarters straight. In the most recent quarter GH Research Plc reported earnings per share of -$0.23.
Enterprise value:
664.2M
EV / Invested capital:
2.27x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-1.87x
EV / Free cash flow:
-15.70x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$325K
Return On Assets:
-16.21%
Net Income Margin (TTM):
--
Return On Equity:
-16.86%
Return On Invested Capital:
-16.82%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$250K | -$315K | -$325K | -$79K | -$89K | |
| Operating Income | -$39.2M | -$48.5M | -$56.9M | -$12.6M | -$16.5M | |
| EBITDA | -$39M | -$48.2M | -$56.6M | -$12.5M | -$16.4M | |
| Diluted EPS | -$0.79 | -$0.80 | -$0.73 | -$0.23 | -$0.23 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $285.6M | $260M | $164M | $154.9M | $294.8M | |
| Total Assets | $285.6M | $260.1M | $232.6M | $199.6M | $302M | |
| Current Liabilities | $2M | $3.4M | $6.1M | $9.8M | $10.4M | |
| Total Liabilities | $2M | $3.4M | $6.8M | $10.2M | $10.6M | |
| Total Equity | $283.6M | $256.7M | $225.8M | $189.4M | $291.4M | |
| Total Debt | -- | -- | $921K | $733K | $582K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$32.6M | -$39.9M | -$42.2M | -$12.7M | -$14.4M | |
| Cash From Investing | -$136.6M | $44.9M | $59M | $15.9M | $10.4M | |
| Cash From Financing | -$164.1K | -$286.4K | $146.1M | -$63.3K | $968.6K | |
| Free Cash Flow | -$32.7M | -$40M | -$42.3M | -$12.7M | -$14.5M | |
GHRS
Sector
Market Cap
$952.2M
$28.8M
Price % of 52-Week High
74.88%
51.13%
Dividend Yield
0%
0%
Shareholder Yield
-16.49%
-1.32%
1-Year Price Total Return
91.88%
-20.64%
Beta (5-Year)
--
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$14.67
200-day SMA
Buy
Level
$12.63
Bollinger Bands (100)
Buy
Level
12.6 - 14.96
Chaikin Money Flow
Sell
Level
-12.2M
20-day SMA
Buy
Level
$14.25
Relative Strength Index (RSI14)
Buy
Level
59.47
ADX Line
Buy
Level
11.94
Williams %R
Sell
Level
-6.25
50-day SMA
Buy
Level
$13.82
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
10.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (22.6948)
Buy
CA Score
(Annual)
Level (0.5525)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (5.5138)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Stock Forecast FAQ
In the current month, GHRS has received 5 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GHRS average analyst price target in the past 3 months is $30.38.
-
Where Will GH Research Plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that GH Research Plc share price will rise to $30.38 per share over the next 12 months.
-
What Do Analysts Say About GH Research Plc?
Analysts are divided on their view about GH Research Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that GH Research Plc is a Sell and believe this share price will drop from its current level to $19.00.
-
What Is GH Research Plc's Price Target?
The price target for GH Research Plc over the next 1-year time period is forecast to be $30.38 according to 5 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GHRS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for GH Research Plc is a Buy. 5 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GHRS?
You can purchase shares of GH Research Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase GH Research Plc shares.
-
What Is The GH Research Plc Share Price Today?
GH Research Plc was last trading at $15.32 per share. This represents the most recent stock quote for GH Research Plc. Yesterday, GH Research Plc closed at $15.35 per share.
-
How To Buy GH Research Plc Stock Online?
In order to purchase GH Research Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get GHRS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GHRS
Sector
P/E ratio
--
23.71x
PEG ratio
-1.87x
-0.01x
P/B ratio
3.27x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
GHRS
Sector
Revenue growth
--
4.85%
Earnings growth
2.92%
11.15%
Revenue (5-year growth)
--
6.45%
Earnings forecast
-$0.23
-$0.20
Profitability
GHRS
Sector
Profitability FY 2024
-$315K
$3.6M
Return on invested capital
-16.82%
-30.98%
Return on assets
-16.21%
-27.62%
Return on equity
-16.86%
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
GHRS
Sector
Total cash
$288.5M
$27.2M
Short term investments
$48.5M
$25.7M
Total assets
$188.3M
$79.7M
Long term debt
$582K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
